Disruptions to schistosomiasis programmes due to COVID-19: an analysis of potential impact and mitigation strategies
<br><strong>Background<br></strong> The 2030 goal for schistosomiasis is elimination as a public health problem (EPHP), with mass drug administration (MDA) of praziquantel to school-age children (SAC) as a central pillar of the strategy. However, due to coronavirus disease 20...
| Huvudupphovsmän: | , , , , |
|---|---|
| Materialtyp: | Journal article |
| Språk: | English |
| Publicerad: |
Oxford University Press
2021
|